EPISODE · Dec 19, 2022 · 1H 4M
Ep125: Barry Greene on a New Drug for Depression
from The Long Run with Luke Timmerman · host Timmerman Report
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.
What this episode covers
Barry Greene, CEO of Cambridge, Mass.-based Sage Therapeutics, on plans to introduce a new type of treatment for depression and postpartum depression.
NOW PLAYING
Ep125: Barry Greene on a New Drug for Depression
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m